Browse Studies — Arctuva

Phase 1

Pilot/Phase I Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT)

This study is for participants whose cancer is oligometastatic, meaning it has spread to up to five spots in their body and their doctor recommends that they h…

OligometastasisOligometastatic Disease

Estimated

~$10 – $6,250

Case Comprehensive Cancer CenterNCT07079098

Phase 1

IT2023-08-ATKINS-ATHERO-RT: Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

The prospective single-arm pilot study, ATHERO-RT: Real-Time Atherosclerosis Activity after Thoracic Radiotherapy using Sodium Fluoride Positron Emission Tomog…

Oligometastatic Disease

Estimated

~$10 – $7,500

Katelyn AtkinsNCT06373497

Phase 2

Phase 2 Randomized Total Eradication of Metastatic Lesions Following Definitive Radiation to the Prostate in de Novo oligometaStatic Prostate Cancer (TERPS) Trial

This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.

Prostate CancerOligometastatic Disease

Estimated

~$10 – $6,250

University of Maryland, BaltimoreNCT05223803

Observational

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing to Improve Outcomes for Patients With Limited Metastatic Disease That Failed First-Line Systemic Therapy

This is a feasibility trial to assess use of OncoTarget and OncoTreat testing in a basket design of patients with oligmetastasis across various solid tumor his…

Personalized MedicineOligometastatic DiseaseFeasibility

Estimated

~$10 – $6,250

Good Samaritan Hospital Medical Center, New YorkNCT06842030